Teladoc health, inc. (TDOC)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Cash flows used in operating activities:
Net loss

-98,864

-97,084

-106,782

-74,216

-58,020

-17,037

-6,019

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization

44,952

35,602

19,095

8,270

4,863

2,320

754

Allowance for doubtful accounts

2,665

2,243

1,731

2,412

2,034

1,308

504

Stock-based compensation

66,702

43,769

30,597

7,723

3,075

533

298

Deferred income taxes

-10,868

-2,247

-306

510

36

388

94

Accretion of interest

25,438

19,487

6,382

262

460

106

2

Amortization of warrants and loss on extinguishment of debt

0

0

14,122

7,717

798

-

-

Gain on sale

0

5,500

0

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

15,884

10,931

3,659

2,900

6,795

5,079

928

Due from officer

-

-

-

-

-

-

253

Prepaid expenses and other current assets

2,685

2,612

2,003

826

957

436

663

Other assets

105

414

-98

42

-5

185

-37

Accounts payable

905

-391

1,534

-813

-612

2,099

-1,099

Accrued expenses and other current liabilities

14,841

3,993

4,292

-2,301

3,457

-26

329

Accrued compensation

4,546

8,480

3,768

1,688

2,887

1,971

802

Operating lease liabilities

-2,417

0

0

-

-

-

-

Other liabilities

643

745

-3,310

641

1,588

2,679

89

Net cash used in operating activities

29,869

-4,860

-34,441

-51,875

-47,181

-11,359

-6,053

Cash flows provided by (used in) investing activities:
Purchase of property and equipment

3,510

4,011

2,633

2,108

6,275

1,069

204

Purchase of internal-use software

7,390

4,396

2,882

1,304

1,542

665

1,090

Purchase of marketable securities

0

56,347

149,261

44,146

103,030

-

-

Proceeds from marketable securities

52,100

84,170

85,753

110,717

20,411

-

-

Sale of assets

0

5,530

0

-

-

-

-

Investment in securities

5,000

0

0

-

-

-

-

Acquisition of business, net of cash acquired

11,187

282,442

379,356

37,013

17,767

13,844

16,462

Net cash (used in) provided by investing activities

25,013

-257,496

-448,379

26,146

-108,203

-15,578

-17,756

Cash flows provided by financing activities:
Net proceeds from the exercise of stock options

33,283

31,322

10,837

2,524

428

747

595

Proceeds from issuance of convertible notes

0

279,152

263,722

-

-

-

-

Proceeds from borrowing under bank and other debt

0

10

166,679

34,990

6,800

19,700

3,000

Repayment of debt

0

0

226,440

17,166

6,332

-

-

Proceeds from issuance of common stock

0

330,843

258,554

250

163,118

-

-

Proceeds from employee stock purchase plan

3,380

2,564

2,153

-

-

-

-

Cash received for withholding taxes on stock-based compensation, net

-1,569

1,721

-74

80

-

-

-

Proceeds from issuance of convertible preferred stock

-

-

-

-

-

50,082

14,803

Repurchase of stock

-

-

-

-

-

368

71

Net cash provided by financing activities

35,094

645,612

475,431

20,678

164,014

70,161

18,327

Net (decrease) increase in cash and cash equivalents

89,976

383,256

-7,389

-5,051

8,630

43,224

-5,482

Foreign exchange difference

388

-2,084

191

-

-

-

-

Income taxes paid

1,310

441

137

-

-

-

-

Interest paid

12,224

10,303

9,450

2,387

1,995

1,191

32